Skye Bioscience, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Skye Bioscience files an amendment to its S-1 registration statement to correct a scrivener's error in the auditor's report regarding the date of the original report.
NASDAQ
S-1: Skye Bioscience Files for Resale of Up to 33.7 Million Shares After Merger and Private Placements
Skye Bioscience registers for the potential resale of up to 33.7 million shares of common stock by selling securityholders following a merger and several private placements.